A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and Interrelatedness

Summary

The study aimed to provide insights in the coordination between trunk, shoulder and upper limb while reaching. Two main phases are present in this study:

In phase A: the psychometric properties of two tests: Clinical Scapular protocol (ClinScaP) in PwMS (Persons with Multiple Sclerosis) and healthy controls.

1. To investigate the test-retest reliability of the Clinical Scapular Protocol (ClinScaP) and the Reaching Performance Scale (RPS) in PwMS
2. To investigate the discriminative of the ClinScaP between PwMS and healthy controls
3. To investigate the discriminative of the RPS between PwMS and healthy controls
4. To investigate the concurrent validity of ClinScaP and RPS in PwMS, compared with upper limb dysfunction measurements.

In phase B:
5. To investigate the prevalence of trunk, scapula and upper limb impairments in PwMS and stroke patients.
6. To investigate the interaction between trunk, scapula and upper limb impairments in PwMS and stroke patients.

Conditions

• Multiple Sclerosis
• Stroke

Interventions

OTHER

Clinical Scapular protocol (ClinScaP)

the psychometric properties of two tests: Clinical Scapular protocol (ClinScaP) in PwMS and healthy controls.

OTHER

the prevalence of trunk, scapula and upper limb impairments.

To investigate the prevalence of trunk, scapula and upper limb impairments in PwMS and stroke patients.

OTHER

the interaction between trunk, scapula and upper limb impairments.

To investigate the interaction between trunk, scapula and upper limb impairments in PwMS and stroke patients.

Sponsors & Collaborators

• Hasselt University

  lead OTHER

• Revalidatie & MS Centrum Overpelt

  collaborator OTHER

• Ziekenhuis Oost-Limburg

  collaborator OTHER

• National MS Center Melsbroek

  collaborator OTHER

• Jessa Hospital

  collaborator OTHER

Principal Investigators

• Ilse Lamers, dr. · Hasselt University

Study Design

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2018-12-12

Primary Completion

2021-08-30

Completion

2022-08-30

Countries

• Belgium

Study Locations